Innate Pharma SA (IPH)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€1.532

Buy

€1.55

arrow-down€-0.018 (-1.16%)

Prices updated at 19 Dec 2025, 16:35 CET

Prices minimum 15 mins delay

Prices in EUR

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in developing immunotherapy drugs for cancer and inflammatory diseases.

FTSE EuroFirst 300

0.43%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	€1.58 - €1.53
	€2.50 - €1.33
	-
	143.06m
	-
	-
	123,939
	27.81
	175,051.12
	0.37
	83.83m
	FR0010331421
	-0.55
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.